Melatonin is commonly known as the sleep hormone, but it should actually be called the darkness hormone,” says neurologist ...

Discover 9 top dividend stocks with 10%+ 5-year return potential based on my valuations and in-depth analysis. Click here.

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...

Not getting enough ZZZs or going to bed late into the night can have an adverse impact on your health and well being. Here’s ...

The recipe to most happy investing outcomes is painfully simple. But if it were that easy, wouldn't everybody do it?

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near ...

Measured by volume, the company makes about 45% of its products in Mexico, with the remainder made in New Zealand ... On ...

Please review our SEC filings for a complete discussion of the risk factors that could cause our actual results to differ materially from any forward-looking statements made today. I'll now turn the ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...